title: American Association of Cancer Research Showcases Immunotherapy Advances.
authors.forename: Vicki
authors.initials: V
authors.lastname: Brower
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000276:immunology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000276:immunology* / Q000627:therapeutic use*; D060890:B7-H1 Antigen / Q000037:antagonists & inhibitors; D019013:CD40 Antigens / Q000276:immunology; D002986:Clinical Trials as Topic / Q000639:trends; D006801:Humans; D007167:Immunotherapy / Q000639:trends*; D008175:Lung Neoplasms / Q000188:drug therapy / Q000276:immunology; D008495:Medical Oncology / Q000639:trends; D008545:Melanoma / Q000188:drug therapy / Q000276:immunology; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology*; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors; D012106:Research / Q000639:trends; D012955:Societies, Medical; D014481:United States
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D060890:B7-H1 Antigen; C423236:CD274 protein, human; D019013:CD40 Antigens; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor; C582435:pembrolizumab; C520704:tremelimumab